دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Contents
doi : 10.1016/S0161-6420(21)00472-3
Volume 128, Issue 9, September 2021, Pages A7, A8, A10, A12, A14, A15, A16
This Issue at a Glance
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.07.006
Volume 128, Issue 9, September 2021, Page 1247
A Simple Vista en Este Número
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.07.004
Volume 128, Issue 9, September 2021, Pages e1-e2
????
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.07.005
Volume 128, Issue 9, September 2021, Page e3
The Unfinished History of Professionalism
George B.BartleyMD
doi : 10.1016/j.ophtha.2021.06.003
Volume 128, Issue 9, September 2021, Pages 1261-1265
Persistent Opioid Use after Ophthalmic Surgery in Opioid-Naive Patients and Associated Risk Factors
CindyUngMD1YoshihiroYonekawaMD5Jennifer F.WaljeeMD, MPH234VidhyaGunaseelanMBA, MHA47Yen-LingLaiMSPH, MS24Maria A.WoodwardMD, MSc6
doi : 10.1016/j.ophtha.2021.04.021
Volume 128, Issue 9, September 2021, Pages 1266-1273
Corneal Manifestations of Miltefosine Toxicity in Acanthamoeba Keratitis
AliceMatobaMD1Mitchell P.WeikertMD1StellaKimMD2
doi : 10.1016/j.ophtha.2021.06.001
Volume 128, Issue 9, September 2021, Page 1273
Opioid Stewardship in Surgical Ophthalmology: Implications for Public Health
William L.LanierMDKeith H.BergeMD
doi : 10.1016/j.ophtha.2021.06.006
Volume 128, Issue 9, September 2021, Pages 1274-1275
OCT Angiography Reveals Bilateral Macular Neovascularization Encircling Macular Atrophy
MarianoCozziMSc1MatteoAiraldiMD1AlessandroInvernizziMD12
doi : 10.1016/j.ophtha.2021.02.023
Volume 128, Issue 9, September 2021, Page 1275
Bidirectional Association between Visual Impairment and Dementia Among Older Adults in the United States Over Time
Stephanie P.ChenMD12Amee D.AzadBA2SuzannPershingMD, MS34
doi : 10.1016/j.ophtha.2021.02.021
Volume 128, Issue 9, September 2021, Pages 1276-1283
Impact of Refractive Outcomes on Bias in Follow-up and Completion of Patient-Reported Outcome Measures after Laser Vision Correction
Julie M.SchallhornMD, MS12Steven C.SchallhornMD13Stephen J.HannanOD4
doi : 10.1016/j.ophtha.2021.01.030
Volume 128, Issue 9, September 2021, Pages 1284-1291
Demographic and Clinical Characteristics Associated with Minimally Invasive Glaucoma Surgery Use: An Intelligent Research in Sight (IRIS®) Registry Retrospective Cohort Analysis
Mildred M.G.OlivierMD1Oluwatosin U.SmithMD2Clarisse C.Croteau-ChonkaPhD3Brian L.VanderBeekMD, MPH, MSCE4Maureen G.MaguirePhD4FloraLumMD5DanielleFujinoMPH5Scott P.KellyPhD5William L.Rich3rd, MD5Eydie G.Miller-EllisMD4
doi : 10.1016/j.ophtha.2021.02.012
Volume 128, Issue 9, September 2021, Pages 1292-1299
Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
NazleeZebardastMD, MS1SayuriSekimitsuBS2JialiWangPhD13TobiasElzePhD4PuyaGharahkhaniPhD5Brian S.ColePhD13Michael M.LinMD1Ayellet V.SegrèPhD13Janey L.WiggsMD, PhD13
doi : 10.1016/j.ophtha.2021.03.007
Volume 128, Issue 9, September 2021, Pages 1300-1311
Time Course of Acute Reversible Clouding of the Hydrophilic Intraocular Lens
Yeon JeongLeeMDSang BeomHanMD
doi : 10.1016/j.ophtha.2021.02.011
Volume 128, Issue 9, September 2021, Page 1311
Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study
YingCuiMD123?YingZhuMD134?Edward S.LuBA3RongrongLeMD, PhD135InêsLaínsMD, PhD13RavivKatzMSc13Jay C.WangMD136ItikaGargMD13YifanLuMD13RebeccaZengBA37DeanEliottMD1Demetrios G.VavvasMD, PhD1DeebaHusainMD1Joan W.MillerMD1Leo A.KimMD, PhD1David M.WuMD, PhD1John B.MillerMD13
doi : 10.1016/j.ophtha.2021.02.020
Volume 128, Issue 9, September 2021, Pages 1312-1324
Spontaneous Regression of Unilateral Conjunctival Primary Acquired Melanosis
LeonardoLandoMDHatemKremaMD, FRCS
doi : 10.1016/j.ophtha.2021.03.001
Volume 128, Issue 9, September 2021, Page 1324
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
Charles C.WykoffMD, PhD1Philip J.RosenfeldMD, PhD2Nadia K.WaheedMD, MPH3Rishi P.SinghMD4NickRoncaMS5Jason S.SlakterMD6GiovanniStaurenghiMD7JordiMonésMD, PhD8Caroline R.BaumalMD3NamrataSarojOD9RaviMetlapallyPhD5RamiroRibeiroMD, PhD5
doi : 10.1016/j.ophtha.2021.02.025
Volume 128, Issue 9, September 2021, Pages 1325-1336
Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis
Nicole K.KellyMPH1AheliChattopadhyayBS1S.R.RathinamMD, PhD2John A.GonzalesMD13RadhikaThundikandyMD2AnuradhaKanakathMD4S. BalaMuruganMD5R.VedhanayakiMD2DeanCugleyMBBS6Lyndell L.LimMBBS, DMedSci6Eric B.SuhlerMD, MPH7Hassan A.Al-DhibiMD8Caleb D.EbertMPH1Elyse J.BerlinbergBS1Travis C.PorcoPhD, MPH139Nisha R.AcharyaMD, MS139
doi : 10.1016/j.ophtha.2021.02.024
Volume 128, Issue 9, September 2021, Pages 1337-1345
Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak
Aline ReetzConceiçãoMD1Deisi NaraBelucikMD1LilianMissioMD1LuizGustavo BrennerMSc1MatheusHenrique MonteiroMD1Kleber SilvaRibeiroPhD2Deise FialhoCostaPhD23Maria Clara da SilvaValadãoMD, PhD1Alessandra GonçalvesCommodaroPhD2João Rafaelde Oliveira DiasMD, PhD2RubensBelfortJr.MD, PhD23
doi : 10.1016/j.ophtha.2021.03.009
Volume 128, Issue 9, September 2021, Pages 1346-1355
Choroidal Effusions and Posterior Scleritis in Idiopathic Orbital Inflammation
David J.DoobinMD, PhDAnn Q.TranMDMichaelKazimMD
doi : 10.1016/j.ophtha.2021.02.018
Volume 128, Issue 9, September 2021, Page 1355
Patient Harm Due to Diagnostic Error of Neuro-Ophthalmologic Conditions
LeanneStunkelMD12Rahul A.SharmaMD3Devin D.MackayMD4BradleyWilsonMA1Gregory P.Van StavernMD12Nancy J.NewmanMD567ValérieBiousseMD56
doi : 10.1016/j.ophtha.2021.03.008
Volume 128, Issue 9, September 2021, Pages 1356-1362
Protecting Patients from the Harm We Can Cause
Prem S.SubramanianMD, PhD
doi : 10.1016/j.ophtha.2021.06.005
Volume 128, Issue 9, September 2021, Pages 1363-1364
Trichomegaly and Trichiasis Associated with Pemigatinib
Giovanni A.CampagnaMD1Sandy T.LiuMD2EdmundTsuiMD1
doi : 10.1016/j.ophtha.2021.02.022
Volume 128, Issue 9, September 2021, Page 1364
Eye Injuries and Visor Use in the National Football League
Arjan S.DhootMD(C)1AlexKoziarzMSc, MD(C)1YerinLeeBSc(C)2ChiragChopraBSc(C)2Jonathan A.MicieliMD, CM34
doi : 10.1016/j.ophtha.2021.01.027
Volume 128, Issue 9, September 2021, Pages 1365-1367
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial
RohitSaxenaMD, PhD1RebikaDhimanMD, MBBS1VinayGuptaBSc1PawanKumarBSc1JyotiMataliaMD, MBBS2LipikaRoyMD, MBBS3MeenakshiSwaminathanMD, MBBS4SwatiPhuljheleMD, MBBS1T.VelpandianMSc, PhD5NamrataSharmaMD, MBBS1
doi : 10.1016/j.ophtha.2021.01.026
Volume 128, Issue 9, September 2021, Pages 1367-1369
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries
Andrew W.StaceyMD1RichardBowmanFRCOphth23AllenFosterFRCOphth2Tero T.KiveläMD4Francis L.MunierMD5NathalieCassouxMD, PhD6Ido DidiFabianMD27
doi : 10.1016/j.ophtha.2021.01.024
Volume 128, Issue 9, September 2021, Pages 1369-1371
Posterior Segment Ophthalmic Manifestations in Ebola Survivors, Sierra Leone
Duncan E.BerryMD1J. ClayBavingerMD1AlcidesFernandesMD1John G.MattiaMD2JalikatuMustaphaMD3LloydHarrison-WilliamsMD3MogesTeshomeMD2Matthew J.VandyMD3Jessica G.ShanthaMD1StevenYehMD14
doi : 10.1016/j.ophtha.2021.02.001
Volume 128, Issue 9, September 2021, Pages 1371-1373
Re: Stunkel et al.: Patient harm due to diagnostic error of neuro-ophthalmologic conditions (Ophthalmology. 2021;128:1356–1362)
Joshua PaulHarveyBM, FRCOphth
doi : 10.1016/j.ophtha.2021.05.006
Volume 128, Issue 9, September 2021, Page e42
Reply
LeanneStunkelMD12Rahul A.SharmaMD3Devin D.MackayMD4BradleyWilsonMA1Gregory P.Van StavernMD12Nancy J.NewmanMD567ValérieBiousseMD56
doi : 10.1016/j.ophtha.2021.05.007
Volume 128, Issue 9, September 2021, Pages e42-e43
Re: Magone et al.: Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor (Ophthalmology. 2021;128:624–626)
Jasmine H.FrancisMD, FACSJuliaCanestraroODDavid H.AbramsonMD, FACS
doi : 10.1016/j.ophtha.2021.05.012
Volume 128, Issue 9, September 2021, Pages e43-e44
Reply
M. TeresaMagoneMD1Iris R.HartleyMD23EdmondFitzGibbonMD1RachelBishopMD1MikeArango4SusanMoranMD, MSCE4RooVoldMD4Jaydira delRiveroMD5KarenPozoRN3JamieStreitRN3Kelly L.RoszkoMD3Michael T.CollinsMD3Rachel I.GafniMD3
doi : 10.1016/j.ophtha.2021.05.015
Volume 128, Issue 9, September 2021, Pages e44-e45
Re: Lois et al.: Evaluation of a new model of care for people with complications of diabetic retinopathy: The EMERALD Study (Ophthalmology. 2021;128:561–573)
PiotrKanclerzMD, PhD12IdanHechtMD234RaimoTuuminenMD, PhD25
doi : 10.1016/j.ophtha.2021.05.013
Volume 128, Issue 9, September 2021, Pages e45-e46
Reply
NoemiLoisMD, PhD
doi : 10.1016/j.ophtha.2021.05.014
Volume 128, Issue 9, September 2021, Pages e46-e47
Re: Monés et al.: Risk of inflammation, retinal vasculitis, and retinal occlusion–related events with brolucizumab: post hoc review of HAWK and HARRIER (Ophthalmology. 2021;128:1050–1059)
DhananjayShuklaMS, MAMS
doi : 10.1016/j.ophtha.2021.04.029
Volume 128, Issue 9, September 2021, Page e47
Reply
Jeffrey S.HeierMD
doi : 10.1016/j.ophtha.2021.04.030
Volume 128, Issue 9, September 2021, Pages e47-e48
